Search

Khoi H Tran

Supervisory Patent Examiner (ID: 6826, Phone: (571)272-6919 , Office: P/3664 )

Most Active Art Unit
3651
Art Unit(s)
3101, 3664, 3615, 3651
Total Applications
1154
Issued Applications
874
Pending Applications
133
Abandoned Applications
147

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17443757 [patent_doc_number] => 20220064262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => FUSION PROTEINS COMPRISING PDGF AND VEGF BINDING PORTIONS AND METHODS OF USING THEREOF [patent_app_type] => utility [patent_app_number] => 17/367027 [patent_app_country] => US [patent_app_date] => 2021-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27169 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17367027 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/367027
FUSION PROTEINS COMPRISING PDGF AND VEGF BINDING PORTIONS AND METHODS OF USING THEREOF Jul 1, 2021 Pending
Array ( [id] => 17258833 [patent_doc_number] => 20210371818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-02 [patent_title] => METHOD FOR INDUCING DIFFERENTIATION OF CORNEAL EPITHELIAL CELLS FROM PLURIPOTENT STEM CELLS [patent_app_type] => utility [patent_app_number] => 17/348174 [patent_app_country] => US [patent_app_date] => 2021-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9247 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17348174 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/348174
METHOD FOR INDUCING DIFFERENTIATION OF CORNEAL EPITHELIAL CELLS FROM PLURIPOTENT STEM CELLS Jun 14, 2021 Pending
Array ( [id] => 17126483 [patent_doc_number] => 20210301251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-30 [patent_title] => METHODS FOR GENERATING AND USING ORGANOIDS AND TISSUE THEREIN [patent_app_type] => utility [patent_app_number] => 17/344064 [patent_app_country] => US [patent_app_date] => 2021-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11225 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17344064 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/344064
METHODS FOR GENERATING AND USING ORGANOIDS AND TISSUE THEREIN Jun 9, 2021 Pending
Array ( [id] => 17604268 [patent_doc_number] => 11332741 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-05-17 [patent_title] => Compositions and methods for treating leber's hereditary optic neuropathy [patent_app_type] => utility [patent_app_number] => 17/320388 [patent_app_country] => US [patent_app_date] => 2021-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 24971 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320388 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/320388
Compositions and methods for treating leber's hereditary optic neuropathy May 13, 2021 Issued
Array ( [id] => 18995995 [patent_doc_number] => 11912823 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-27 [patent_title] => Methods of preparing a poloxamer for use in cell culture medium [patent_app_type] => utility [patent_app_number] => 17/319886 [patent_app_country] => US [patent_app_date] => 2021-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 22570 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 220 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319886 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/319886
Methods of preparing a poloxamer for use in cell culture medium May 12, 2021 Issued
Array ( [id] => 17214792 [patent_doc_number] => 20210348129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => NON-DECELLULARIZED PLANT LEAF CULTURES FOR MEAT [patent_app_type] => utility [patent_app_number] => 17/317037 [patent_app_country] => US [patent_app_date] => 2021-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8583 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17317037 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/317037
NON-DECELLULARIZED PLANT LEAF CULTURES FOR MEAT May 10, 2021 Pending
Array ( [id] => 17960315 [patent_doc_number] => 20220340895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-27 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY [patent_app_type] => utility [patent_app_number] => 17/317295 [patent_app_country] => US [patent_app_date] => 2021-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24683 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17317295 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/317295
COMPOSITIONS AND METHODS FOR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY May 10, 2021 Pending
Array ( [id] => 17355410 [patent_doc_number] => 20220016206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => ISOFORM NELL-1 PEPTIDE [patent_app_type] => utility [patent_app_number] => 17/315593 [patent_app_country] => US [patent_app_date] => 2021-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8469 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17315593 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/315593
ISOFORM NELL-1 PEPTIDE May 9, 2021 Pending
Array ( [id] => 18964417 [patent_doc_number] => 11898169 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-13 [patent_title] => Synergistic genome-nonintegrating reprogramming by microRNAs and transcription factors [patent_app_type] => utility [patent_app_number] => 17/239059 [patent_app_country] => US [patent_app_date] => 2021-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 18 [patent_no_of_words] => 11515 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17239059 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/239059
Synergistic genome-nonintegrating reprogramming by microRNAs and transcription factors Apr 22, 2021 Issued
Array ( [id] => 16990225 [patent_doc_number] => 20210228645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => METHODS FOR PRODUCING RETINAL TISSUE AND RETINA-RELATED CELL [patent_app_type] => utility [patent_app_number] => 17/227497 [patent_app_country] => US [patent_app_date] => 2021-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15283 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227497 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/227497
METHODS FOR PRODUCING RETINAL TISSUE AND RETINA-RELATED CELL Apr 11, 2021 Pending
Array ( [id] => 16961569 [patent_doc_number] => 20210213068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-15 [patent_title] => PLURIPOTENT STEM CELL FOR TREATMENT OF CEREBRAL INFARCTION [patent_app_type] => utility [patent_app_number] => 17/219430 [patent_app_country] => US [patent_app_date] => 2021-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6098 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219430 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/219430
PLURIPOTENT STEM CELL FOR TREATMENT OF CEREBRAL INFARCTION Mar 30, 2021 Pending
Array ( [id] => 17814310 [patent_doc_number] => 11419898 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-23 [patent_title] => Combinatorial cancer immunotherapy [patent_app_type] => utility [patent_app_number] => 17/219569 [patent_app_country] => US [patent_app_date] => 2021-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 120 [patent_figures_cnt] => 122 [patent_no_of_words] => 62423 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 329 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219569 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/219569
Combinatorial cancer immunotherapy Mar 30, 2021 Issued
Array ( [id] => 17228682 [patent_doc_number] => 20210355238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => NON-HUMAN ANIMALS THAT SELECT FOR LIGHT CHAIN VARIABLE REGIONS THAT BIND ANTIGEN [patent_app_type] => utility [patent_app_number] => 17/204253 [patent_app_country] => US [patent_app_date] => 2021-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54714 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204253 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/204253
NON-HUMAN ANIMALS THAT SELECT FOR LIGHT CHAIN VARIABLE REGIONS THAT BIND ANTIGEN Mar 16, 2021 Pending
Array ( [id] => 16913995 [patent_doc_number] => 20210187087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => TARGETING DNA VACCINES TO B CELLS AS PRIMARY ANTIGEN PRESENTING CELLS [patent_app_type] => utility [patent_app_number] => 17/191378 [patent_app_country] => US [patent_app_date] => 2021-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10173 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 208 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17191378 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/191378
TARGETING DNA VACCINES TO B CELLS AS PRIMARY ANTIGEN PRESENTING CELLS Mar 2, 2021 Pending
Array ( [id] => 16913975 [patent_doc_number] => 20210187067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => TREATMENT OF DISEASES INVOLVING DEFICIENCY OF ENPP1 OR ENPP3 [patent_app_type] => utility [patent_app_number] => 17/178127 [patent_app_country] => US [patent_app_date] => 2021-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42781 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178127 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/178127
TREATMENT OF DISEASES INVOLVING DEFICIENCY OF ENPP1 OR ENPP3 Feb 16, 2021 Abandoned
Array ( [id] => 16822763 [patent_doc_number] => 20210138056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => NEOEPITOPE VACCINE COMPOSITIONS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/148324 [patent_app_country] => US [patent_app_date] => 2021-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51532 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17148324 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/148324
NEOEPITOPE VACCINE COMPOSITIONS AND METHODS OF USE THEREOF Jan 12, 2021 Abandoned
Array ( [id] => 16977966 [patent_doc_number] => 20210222203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => RXR-ALPHA GENE KNOCKOUT CELL LINE WITH STABLE AND LOW RXR-ALPHA PROTEIN EXPRESSION AND PRODUCTION METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 17/135916 [patent_app_country] => US [patent_app_date] => 2020-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3608 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17135916 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/135916
RXR-ALPHA GENE KNOCKOUT CELL LINE WITH STABLE AND LOW RXR-ALPHA PROTEIN EXPRESSION AND PRODUCTION METHOD THEREOF Dec 27, 2020 Pending
Array ( [id] => 16825672 [patent_doc_number] => 20210140965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => CORNEAL ENDOTHELIAL CELL MARKER [patent_app_type] => utility [patent_app_number] => 17/133326 [patent_app_country] => US [patent_app_date] => 2020-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28490 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17133326 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/133326
CORNEAL ENDOTHELIAL CELL MARKER Dec 22, 2020 Pending
Array ( [id] => 16760451 [patent_doc_number] => 20210106032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-15 [patent_title] => APPARATUSES AND METHODS FOR PREPARING A COMESTIBLE MEAT PRODUCT [patent_app_type] => utility [patent_app_number] => 17/131514 [patent_app_country] => US [patent_app_date] => 2020-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17647 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17131514 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/131514
Apparatuses and methods for preparing a comestible meat product Dec 21, 2020 Issued
Array ( [id] => 16760403 [patent_doc_number] => 20210105984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-15 [patent_title] => ADAM6 MICE [patent_app_type] => utility [patent_app_number] => 17/129706 [patent_app_country] => US [patent_app_date] => 2020-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43606 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17129706 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/129706
ADAM6 MICE Dec 20, 2020 Pending
Menu